BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20663695)

  • 1. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
    Guillemi S; Harris M; Bondy GP; Ng F; Zhang W; Lima VD; Michaels CE; Belzberg A; Montaner JS
    J Clin Densitom; 2010; 13(4):456-61. PubMed ID: 20663695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
    Pinto Neto LF; Ragi-Eis S; Vieira NF; Soprani M; Neves MB; Ribeiro-Rodrigues R; Miranda AE
    J Clin Densitom; 2011; 14(4):434-9. PubMed ID: 22051092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.
    Calmy A; Fux CA; Norris R; Vallier N; Delhumeau C; Samaras K; Hesse K; Hirschel B; Cooper DA; Carr A
    J Infect Dis; 2009 Dec; 200(11):1746-54. PubMed ID: 19874178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMD is reduced in HIV-infected men irrespective of treatment.
    Amiel C; Ostertag A; Slama L; Baudoin C; N'Guyen T; Lajeunie E; Neit-Ngeilh L; Rozenbaum W; De Vernejoul MC
    J Bone Miner Res; 2004 Mar; 19(3):402-9. PubMed ID: 15040828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A; Pinheiro MF; Mendonça LM; Gouveia C; Luiz RR; Machado ES; Farias ML
    Int J Infect Dis; 2012 Dec; 16(12):e872-8. PubMed ID: 23031418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
    J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of osteoporosis in female SLE patients-extended report.
    Almehed K; Forsblad d'Elia H; Kvist G; Ohlsson C; Carlsten H
    Rheumatology (Oxford); 2007 Jul; 46(7):1185-90. PubMed ID: 17500075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
    Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
    Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of osteoporosis in Thai men.
    Pongchaiyakul C; Apinyanurag C; Soontrapa S; Soontrapa S; Pongchaiyakul C; Nguyen TV; Rajatanavin R
    J Med Assoc Thai; 2006 Feb; 89(2):160-9. PubMed ID: 16579001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
    J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
    Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
    HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
    Patel R; Blake GM; Fogelman I
    Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
    Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
    Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
    de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH
    Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.